Filed before 2025Filed 3 November 2023
Ordaos, Inc. raised $1.8M
Ordaos, Inc., a biotech company based in New York, NY, raised $1.8M in a new convertible round, according to a filing dated 3 November 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 3 November 2023
- Round
- Convertible round
- Amount sold
- $1.8M
- Offering size
- $5M
- Investors so far
- 4
- Based in
- New York, NY
- Website
- ordaos.bio
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 19% of the 1,396 tracked raises with an amount filed in 2023, and than 20% of the 142 in biotech.
Ordaos, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 1 Apr 2025 | New filing | $338K | Another raise |
| 11 Sep 2024 | New filing | $3.1M | Another raise |
| 29 Dec 2023 | New filing | $500K | Another raise |
| 28 Dec 2023 | New filing | $332K | Another raise |
| 3 Nov 2023 | New filing | $1.8M | This raise |
| 15 Jun 2022 | New filing | $10.7M | Another raise |
More with VTC on the board
- TearSolutions, Inc.$517K
- CytoRecovery, Inc.$2.1M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.